All sites C00-96,D32-33,D42-43,D45-47,D76 698 89.6 0.9 5.1 0.8 3.6
Mouth, pharynx C00-14 15 100.0 - - - -
  Lip C00 2 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 5 100.0 - - - -
  Salivary glands C07-08 2 100.0 - - - -
  Pharynx C01,C09-14 3 100.0 - - - -
Digestive organs C15-26 130 78.8 0.5 13.5 1.4 5.8
  Oesophagus C15 3 87.5 - - 6.3 6.3
  Stomach C16 13 87.9 - 6.1 1.5 4.5
  Small intestine C17 3 93.3 - 6.7 - -
  Colon C18 42 94.8 - 3.8 - 1.4
  Rectum, rectosigmoid C19-20 19 94.8 - 2.1 1.0 2.1
  Anus C21 2 100.0 - - - -
  Liver C22 10 70.6 - 23.5 2.0 3.9
  Gallbladder, bile ducts C23-24 9 65.1 4.7 18.6 - 11.6
  Pancreas C25 26 43.2 0.8 39.4 3.8 12.9
  Other digestive organs C26 3 53.8 - 7.7 - 38.5
Respiratory organs C30-39 34 69.6 7.0 14.6 1.2 7.6
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 32 70.0 7.5 15.0 1.3 6.3
  Mediastinum, pleura C38 1 25.0 - 25.0 - 50.0
Bone C40-41 1 80.0 - - - 20.0
Melanoma of the skin C43 26 100.0 - - - -
Skin, non-melanoma C44 43 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 5 100.0 - - - -
Breast C50 200 99.4 - 0.2 0.1 0.3
Female genital organs C51-58 85 96.0 0.5 1.4 0.5 1.6
  Cervix uteri C53 7 100.0 - - - -
  Corpus uteri C54 47 98.7 - - 0.4 0.9
  Uterus, other C55,C58 0 - - 50.0 - 50.0
  Ovary C56 21 90.4 1.9 4.8 - 2.9
  Other female genital C51-52,C57 10 96.0 - - 2.0 2.0
Urinary organs C64-68 38 90.6 - 6.8 - 2.6
  Kidney C64 22 88.4 - 8.9 - 2.7
  Bladder and urinary tract2 C65-68 16 93.8 - 3.8 - 2.5
Eye C69 1 66.7 - - 33.3 -
Brain, central nervous system C70-72,D32-33,D42-43 29 82.6 - 13.2 - 4.2
Thyroid gland C73 20 99.0 - - - 1.0
Other endocrine glands C74-75 0 50.0 - 50.0 - -
Illdefined or unknown C76,C80 13 45.3 4.7 26.6 6.3 17.2
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 57 75.6 3.5 2.5 3.5 14.8
  Hodgkin lymphoma C81 4 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 27 96.4 - 0.7 - 2.9
  Malignant immunoproliferative diseases C88 1 75.0 - - - 25.0
  Myeloma and other plasma cell tumors C90 7 41.7 2.8 16.7 16.7 22.2
  Leukaemia C91-95 11 48.2 14.3 - 7.1 30.4
  Myelodysplastic syndromes D46 2 27.3 - - - 72.7
  Myeloproliferaitive neoplasms D45,D47 4 73.7 5.3 - - 21.1
Not included above
  Carcinoma in situ of the breast D05 14 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 24 100.0 - - - -
  Borderline tumour of the ovary D39 9 100.0 - - - -
  Basal cell carcinoma of the skin 303 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.